Results 181 to 190 of about 21,965 (226)
Some of the next articles are maybe not open access.

Bioseparation Engineering. Selective Purification of HTLV-II p20EII and HTLV-II Virion with Specific Monoclonal Antibody.

KAGAKU KOGAKU RONBUNSHU, 2001
ヒトT細胞白血病ウイルスII型(HTLV-II)特異的なモノクローナル抗体mAbgp21古34を取得した.mAbgp21-34はHTLV-IIのエンベロ-プの膜貫通領域であるp2oEIIを認識する抗体であった.mAbgp21-34固定化Sepharoseを用いてHTLV-及びHTLV-Iウイルスの可溶化液より,p2oEI及びp2oEIIの特異的精製を試みた.mAbgp21-34固定化SepharoseカラムクロマトグラフィーによりHTLV-II由来p2oEIIは特異的に吸着され3MKSCNで溶出されたが,HTLV-1由来p2oEIはカラムに吸着されなかった.mAbgp21-34固定化Sepharoseカラムが相同性の高いウイルス間での型特異的抗原の精製に有用であった ...
Eiji Miyagawa, Shuichi Yamamoto
openaire   +1 more source

HTLV-I and HTLV-II

2003
Human T-cell lymphotropic virus type I (HTLV-I) is known as the causative agent for adult T-cell leukemia (ATL). This same virus was found to be related to another human disease, a progressive spastic paraparesis, found independently in two areas of the world, the Caribbean basin and Japan.
openaire   +2 more sources

HTLV-II Among Injecting Drug Users in Stockholm

Scandinavian Journal of Infectious Diseases, 1994
134 injecting drug users (IDUs) treated at the Department of Infectious Diseases of Roslagstull Hospital, Stockholm, were tested for antibodies to human T-lymphotropic virus, types I and II, by means of 2 HTLV-I/-II peptide-based enzyme immunoassays (EIAs), followed by a whole-virus EIA.
A, Krook, J, Blomberg
openaire   +2 more sources

Chronic neurodegenerative disease associated with HTLV-II infection

The Lancet, 1992
Although human T-cell leukemia virus (HTLV) type I is known to cause a number of diseases, there has been no convincing evidence of pathological changes after infection with the related virus, HTLV-II. We have found an endemic focus of HTLV-II infection among members of an American Indian population in New Mexico, USA.
B. Hjelle   +7 more
openaire   +2 more sources

HTLV-II among Italian intravenous drug users and hemophiliacs

European Journal of Epidemiology, 1992
The seroprevalence of HTLV-I/II was evaluated in 1247 Italian individuals at high risk for HIV infection. The population studied consisted of 985 intravenous drug users (IVDUs), 474 of whom on methadone maintenance and 511 in a therapeutic community, 110 HIV-infected patients in various stages of HIV-related disease and 152 hemophiliacs.
A. R. Zanetti   +11 more
openaire   +2 more sources

HTLV-II transmission to a health care worker

American Journal of Infection Control, 2006
Health care workers, mainly in emergency and forensic services, are at risk of exposure to bloodborne pathogens. Human T-cell lymphotropic virus type I and type II (HTLV-I and HTLV-II) are cosmopolitan human delta retroviruses causing endemic infection in Japan, the Caribbean basin, South America, and sub-Saharan Africa, and in clusters among ...
openaire   +2 more sources

Human Retroviruses: HTLV-I and HTLV-II

1993
Human T-cell leukemia viruses, type I (HTLV-I) and type II (HTLV-II), have been extensively investigated during the past decade. In 1977 Takatsuki and his colleagues first identified adult T-cell leukemia (ATL) as a disease entity characterized by pleomorphic leukemia/lymphoma cells with deformed nuclei and the clustering of patients to southwest Japan
Kazuo Sugamura, Yorio Hinuma
openaire   +1 more source

Seroprevalence of HTLV-I and HTLV-II

New England Journal of Medicine, 1992
R A, LaBrie   +2 more
openaire   +5 more sources

[HTLV-I and HTLV-II virus].

Annales de biologie clinique, 1998
HTLV genomic and antigenic features, replication way as well as associated pathology are recalled herein. The epidemiologic angle and the different transmission ways are also related. HTLV infection diagnostic implements are detailed: screening and specially confirmatory tests are brought to light with the help of concrete examples interpreted ...
openaire   +1 more source

Testing blood donors for HTLV-II

The Lancet, 1993
Mary Brennan   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy